The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Sotio; Tesaro
Travel, Accommodations, Expenses - Medac
Phase II results of GANNET53: A European multicenter phase I/randomized II trial of the Hsp90 inhibitor Ganetespib (G) combined with weekly Paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
 
Nicole Concin
Travel, Accommodations, Expenses - Amgen; Roche
 
Ioana Braicu
Honoraria - Amgen; AstraZeneca; Roche Pharma AG; Tesaro
Consulting or Advisory Role - Amgen
Research Funding - Angle; Aprea AB; Roche; Takeda
Travel, Accommodations, Expenses - Angle
 
Pierre Combe
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Janssen; Novartis; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche; tesaro
 
Philipp Harter
No Relationships to Disclose
 
Pauline Wimberger
No Relationships to Disclose
 
Jean-Pierre Lotz
No Relationships to Disclose
 
Atanas Ignatov
No Relationships to Disclose
 
Barbara Schmalfeldt
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche
 
Els van Nieuwenhuysen
No Relationships to Disclose
 
Silvia Darb-Esfahani
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Marina Riedmann
No Relationships to Disclose
 
Alain G Zeimet
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; Clovis Oncology; Pfizer; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Pfizer; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche
 
Christian Marth
No Relationships to Disclose
 
Regina Berger
Travel, Accommodations, Expenses - Amgen; Roche
 
Jalid Sehouli
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novocure; Roche; Tesaro
Research Funding - Amgen (Inst); Lilly (Inst); Novartis (Inst); RaySearch Laboratories (Inst)
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); Array Biopharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); GE Healthcare (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Intuitive Surgical (Inst); Janssen-Cilag (Inst); Lilly (Inst); MedImmune (Inst); Menarini (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Nektar (Inst); Novo Nordisk (Inst); Oasmia Pharmaceutical AB (Inst); PharmaMar (Inst); Phillips Gilmore Oncology (Inst); Roche (Inst); Sanofi (Inst); Schering-Plough (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Fresenius Biotech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Janssen-Cilag (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Morphotek (Inst); Nektar (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Roche (Inst); Sandoz (Inst); Sanofi (Inst); Schering-Plough (Inst); Tesaro (Inst); Vifor Pharma (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GCI Health; Oasmia Pharmaceutical AB; PharmaMar; Roche